The Cancer Atlas, Fourth Edition
IARC and ACS Launch a Landmark Publication for Global Cancer Control
The International Agency for Research on Cancer (IARC) and the American Cancer Society (ACS) have officially launched The Cancer Atlas, Fourth Edition, a landmark publication designed to shape global strategies across the cancer control continuum.
This edition provides a comprehensive overview of the world’s evolving cancer burden, based on IARC’s robust data and research. It highlights proven and evidence-based interventions to prevent, detect, and control cancer globally.
🔬 According to IARC’s six decades of research, approximately half of all cancer cases are preventable — emphasizing the importance of:
Early detection and screening
Vaccination against HPV and hepatitis B
Reducing alcohol and tobacco use
Access to quality health services
Strengthening health system resilience
IARC’s contributions include chapters on:
Human carcinogens
Cancer and infections
Alcohol and cancer risk
Early detection strategies
Global and site-specific cancer burdens
Cancer survival
Population-based cancer registries
Universal health coverage and health systems
📘 Read the full publication:
🔗 The Cancer Atlas, Fourth Edition
💬 Read quotes and insights from IARC scientists:
🔗 IARC & ACS Launch Announcement
#EuCanScreen #CancerScreening #HealthCare #CancerPrevention #ColorectalCancer
🔗 Please don’t forget to Subscribe to EuCanScreen Newsletter! 💪
Subscribe to our newsletter to get news and updates.
Subscribe to our newsletter to get news and updates.
Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency (HADEA). Neither the European Union nor HADEA can be held responsible for them.
The general objective of EUCanScreen is to assure sustainable implementation of high-quality screening for breast, cervical and colorectal cancers, as well as implementation of the recently recommended screening programs – for lung, prostate and gastric cancers. EUCanScreen will facilitate the reduction of cancer burden and achieving equity across the EU.
This project has received funding from the European Union’s EU4HEALTH Programme under the Grant Agreement no 101162959